Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_assertion type Assertion NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_head.
- NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_assertion description "[The human IGF2-P4 and H19 promoters are highly active in a variety of human cancers (including bladder cancer), while existing at a nearly undetectable level in the surrounding normal tissue.Single promoter vectors expressing diphtheria toxin A-fragment (DTA) under the control regulation of IGF2-P4 or H19 regulatory sequences (IGF2-P4-DTA and H19-DTA) were previously successfully used in cell lines, animal models and recently in human patients with superficial cell carcinoma of the bladder (treated with H19-DTA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_provenance.
- NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_assertion evidence source_evidence_literature NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_provenance.
- NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_assertion SIO_000772 21162716 NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_provenance.
- NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_assertion wasDerivedFrom befree-20140225 NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_provenance.
- NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_assertion wasGeneratedBy ECO_0000203 NP507056.RA_5em2uzUX4AhdhWxkj7wCv6H3qTSjfDyjC-cBAV6w7Q130_provenance.